仙乐健康
(300791)
| 流通市值：53.34亿 | | | 总市值：64.58亿 |
| 流通股本：1.50亿 | | | 总股本：1.82亿 |
| 报告期 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 2,502,922,802.68 | 1,544,847,837.25 | 702,158,705.58 | 2,507,261,818.8 |
| 营业收入 | 2,502,922,802.68 | 1,544,847,837.25 | 702,158,705.58 | 2,507,261,818.8 |
| 二、营业总成本 | 2,305,834,727.33 | 1,444,525,424.24 | 683,269,157.07 | 2,262,871,938.88 |
| 营业成本 | 1,748,274,556.78 | 1,089,856,315.5 | 507,878,014.52 | 1,725,556,816.11 |
| 税金及附加 | 15,957,547.11 | 9,451,541.02 | 4,583,866.33 | 14,854,056.28 |
| 销售费用 | 185,346,698.1 | 114,345,161.14 | 52,297,298.08 | 130,133,955.67 |
| 管理费用 | 245,462,851.88 | 165,414,017.62 | 83,050,186.67 | 304,441,191.12 |
| 研发费用 | 75,471,289.32 | 46,496,020.83 | 22,478,475.33 | 80,716,052.58 |
| 财务费用 | 35,321,784.14 | 18,962,368.13 | 12,201,209.93 | 7,169,867.12 |
| 其中:利息费用 | 50,001,367.73 | 32,023,686.22 | 11,564,701.01 | 42,770,993.8 |
| 其中:利息收入 | 8,762,653.19 | 3,261,766.03 | 1,791,638.1 | 11,578,049.84 |
| 加:公允价值变动收益 | -12,816,293.78 | -6,978,164.34 | 800,273.96 | -1,637,718.52 |
| 加:投资收益 | 3,981,765.21 | 2,688,543.93 | 994,849.33 | 23,394,651.96 |
| 资产处置收益 | 22,900.05 | 47,109.17 | - | 143,928.81 |
| 资产减值损失(新) | -828,294.24 | -2,242,170.86 | -397,782.86 | -4,976,789.32 |
| 信用减值损失(新) | -451,130.78 | 2,421,536.2 | 1,699,011.21 | -3,993,366.28 |
| 其他收益 | 10,562,398.72 | 6,679,847.43 | 2,979,330.1 | 7,735,394.29 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 197,559,420.53 | 102,939,114.54 | 24,965,230.25 | 265,055,980.86 |
| 加:营业外收入 | 1,285,430.95 | 536,648.63 | 244,593.61 | 848,826.71 |
| 减:营业外支出 | 2,111,441.04 | 727,865.85 | 286,102.48 | 14,386,479.59 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 196,733,410.44 | 102,747,897.32 | 24,923,721.38 | 251,518,327.98 |
| 减:所得税费用 | 37,032,497.02 | 22,803,586.87 | 6,165,404.2 | 39,232,749.89 |
| 六、净利润 | 159,700,913.42 | 79,944,310.45 | 18,758,317.18 | 212,285,578.09 |
| 持续经营净利润 | 159,700,913.42 | 79,944,310.45 | 18,758,317.18 | 212,285,578.09 |
| 归属于母公司股东的净利润 | 185,147,820.63 | 101,185,645.67 | 29,399,867.21 | 212,285,578.09 |
| 少数股东损益 | -25,446,907.21 | -21,241,335.22 | -10,641,550.03 | 0 |
| (一)基本每股收益 | 1.03 | 0.56 | 0.16 | 1.18 |
| (二)稀释每股收益 | 1.03 | 0.56 | 0.19 | 1.17 |
| 八、其他综合收益 | 73,625,275.16 | 76,347,618.77 | -129,634,097.86 | 13,791,112.17 |
| 归属于母公司股东的其他综合收益 | 70,485,395.12 | 74,560,549.63 | -102,206,070.76 | 13,791,112.17 |
| 九、综合收益总额 | 233,326,188.58 | 156,291,929.22 | -110,875,780.68 | 226,076,690.26 |
| 归属于母公司股东的综合收益总额 | 255,633,215.75 | 175,746,195.3 | -72,806,203.55 | 226,076,690.26 |
| 归属于少数股东的综合收益总额 | -22,307,027.17 | -19,454,266.08 | -38,069,577.13 | - |
| 公告日期 | 2023-10-26 | 2023-08-25 | 2023-04-28 | 2023-04-21 |
| 审计意见(境内) | | | | 标准无保留意见 |